Your browser doesn't support javascript.
loading
Biallelic variants in ZNF142 lead to a syndromic neurodevelopmental disorder.
Christensen, Maria B; Levy, Amanda M; Mohammadi, Nazanin A; Niceta, Marcello; Kaiyrzhanov, Rauan; Dentici, Maria Lisa; Al Alam, Chadi; Alesi, Viola; Benoit, Valérie; Bhatia, Kailash P; Bierhals, Tatjana; Boßelmann, Christian M; Buratti, Julien; Callewaert, Bert; Ceulemans, Berten; Charles, Perrine; De Wachter, Matthias; Dehghani, Mohammadreza; D'haenens, Erika; Doco-Fenzy, Martine; Geßner, Michaela; Gobert, Cyrielle; Guliyeva, Ulviyya; Haack, Tobias B; Hammer, Trine B; Heinrich, Tilman; Hempel, Maja; Herget, Theresia; Hoffmann, Ute; Horvath, Judit; Houlden, Henry; Keren, Boris; Kresge, Christina; Kumps, Candy; Lederer, Damien; Lermine, Alban; Magrinelli, Francesca; Maroofian, Reza; Vahidi Mehrjardi, Mohammad Yahya; Moudi, Mahdiyeh; Müller, Amelie J; Oostra, Anna J; Pletcher, Beth A; Ros-Pardo, David; Samarasekera, Shanika; Tartaglia, Marco; Van Schil, Kristof; Vogt, Julie; Wassmer, Evangeline; Winkelmann, Juliane.
Affiliation
  • Christensen MB; Department of Clinical Genetics, Copenhagen University Hospital, Copenhagen, Denmark.
  • Levy AM; Kennedy Center, Department of Clinical Genetics, Copenhagen University Hospital, Copenhagen, Denmark.
  • Mohammadi NA; Department of Epilepsy Genetics and Personalized Treatment, The Danish Epilepsy Centre, Dianalund, Denmark.
  • Niceta M; Department of Regional Health Research, University of Southern Denmark, Odense, Denmark.
  • Kaiyrzhanov R; Genetics and Rare Diseases Research Division, Ospedale Pediatrico Bambino Gesù, IRCCS, Rome, Italy.
  • Dentici ML; Department of Neuromuscular Disorders, University College London Institute of Neurology, London, UK.
  • Al Alam C; Genetics and Rare Diseases Research Division, Ospedale Pediatrico Bambino Gesù, IRCCS, Rome, Italy.
  • Alesi V; Medical Genetics Unit, Academic Department of Pediatrics, Bambino Gesù Children's Hospital, IRCCS, Rome, Italy.
  • Benoit V; Pediatric Neurology department, American center for Psychiatry and Neurology, Al Ain, United Arab Emirates.
  • Bhatia KP; Pediatric Neurology department, Haykel Hospital, El Koura, Lebanon.
  • Bierhals T; Translational Cytogenomics Research Unit, Ospedale Pediatrico Bambino Gesù, IRCCS, Rome, Italy.
  • Boßelmann CM; IPG, Centre for Human Genetics, Charleroi, Belgium.
  • Buratti J; Department of Clinical and Movement Neurosciences, UCL Queen Square Institute of Neurology, University College London, London, UK.
  • Callewaert B; Institute of Human Genetics, University Medical Center Hamburg-Eppendorf, Hamburg, Germany.
  • Ceulemans B; Department of Neurology and Epileptology, Hertie-Institute for Clinical Brain Research, University of Tübingen, Tübingen, Germany.
  • Charles P; Department of Medical Genetics, Pitié-Salpêtrière Hospital, AP-HP, Sorbonne Université, Paris, France.
  • De Wachter M; Center for Medical Genetics, Ghent University Hospital, Ghent, Belgium.
  • Dehghani M; Department of Biomolecular Medicine, Ghent University, Ghent, Belgium.
  • D'haenens E; Department of Pediatric Neurology, Antwerp University Hospital, University of Antwerp, Edegem, Belgium.
  • Doco-Fenzy M; Department of Medical Genetics, Pitié-Salpêtrière Hospital, AP-HP, Sorbonne Université, Paris, France.
  • Geßner M; Department of Pediatric Neurology, Antwerp University Hospital, University of Antwerp, Edegem, Belgium.
  • Gobert C; Medical Genetics Research Center, Shahid Sadoughi University of Medical Sciences, Yazd, Iran.
  • Guliyeva U; Center for Medical Genetics, Ghent University Hospital, Ghent, Belgium.
  • Haack TB; SFR CAP SANTE, HMB2 CHU Reims, Reims, France.
  • Hammer TB; CHU de Nantes, service de génétique médicale, Nantes, France.
  • Heinrich T; KfH-Board of Trustees for Dialysis and Kidney Transplantation (KfH-Kuratorium für Dialyse und Nierentransplantation e.V.), Neu Isenburg, Germany.
  • Hempel M; Neuropediatric department, Centre Hospitalier Neurologique William Lennox, Ottignies, Belgium.
  • Herget T; Department of Pediatrics, MediClub Hospital, Baku, Azerbaijan.
  • Hoffmann U; Institute of Medical Genetics and Applied Genomics, University of Tübingen, Tübingen, Germany.
  • Horvath J; Centre for Rare Diseases, University of Tübingen, Tübingen, Germany.
  • Houlden H; Department of Clinical Genetics, Copenhagen University Hospital, Copenhagen, Denmark.
  • Keren B; Department of Epilepsy Genetics and Personalized Treatment, The Danish Epilepsy Centre, Dianalund, Denmark.
  • Kresge C; Institute of Medical Genetics and Applied Genomics, University of Tübingen, Tübingen, Germany.
  • Kumps C; MVZ Humangenetik und Molekularpathologie GmbH, Rostock, Germany.
  • Lederer D; Institute of Human Genetics, University Medical Center Hamburg-Eppendorf, Hamburg, Germany.
  • Lermine A; Institute of Human Genetics, University Medical Center Hamburg-Eppendorf, Hamburg, Germany.
  • Magrinelli F; St. Franziskus-Hospital, Münster, Germany.
  • Maroofian R; Institute of Human Genetics, University of Münster, Münster, Germany.
  • Vahidi Mehrjardi MY; Department of Neuromuscular Disorders, University College London Institute of Neurology, London, UK.
  • Moudi M; Department of Medical Genetics, Pitié-Salpêtrière Hospital, AP-HP, Sorbonne Université, Paris, France.
  • Müller AJ; Department of Pediatrics, Rutgers New Jersey Medical School, Newark, New Jersey, USA.
  • Oostra AJ; Center for Medical Genetics, Ghent University Hospital, Ghent, Belgium.
  • Pletcher BA; Department of Biomolecular Medicine, Ghent University, Ghent, Belgium.
  • Ros-Pardo D; IPG, Centre for Human Genetics, Charleroi, Belgium.
  • Samarasekera S; LBBMS SeqOIA, AP-HP, Paris, France.
  • Tartaglia M; Department of Clinical and Movement Neurosciences, UCL Queen Square Institute of Neurology, University College London, London, UK.
  • Van Schil K; Department of Neuromuscular Disorders, University College London Institute of Neurology, London, UK.
  • Vogt J; Medical Genetics Research Center, Shahid Sadoughi University of Medical Sciences, Yazd, Iran.
  • Wassmer E; Department of Genetics, Shahid Sadoughi University of Medical Sciences, Yazd, Iran.
  • Winkelmann J; Institute of Medical Genetics and Applied Genomics, University of Tübingen, Tübingen, Germany.
Clin Genet ; 102(2): 98-109, 2022 08.
Article in En | MEDLINE | ID: mdl-35616059
ABSTRACT
Biallelic variants of the gene encoding for the zinc-finger protein 142 (ZNF142) have recently been associated with intellectual disability (ID), speech impairment, seizures, and movement disorders in nine individuals from five families. In this study, we obtained phenotype and genotype information of 26 further individuals from 16 families. Among the 27 different ZNF142 variants identified in the total of 35 individuals only four were missense. Missense variants may give a milder phenotype by changing the local structure of ZF motifs as suggested by protein modeling; but this correlation should be validated in larger cohorts and pathogenicity of the missense variants should be investigated with functional studies. Clinical features of the 35 individuals suggest that biallelic ZNF142 variants lead to a syndromic neurodevelopmental disorder with mild to moderate ID, varying degrees of delay in language and gross motor development, early onset seizures, hypotonia, behavioral features, movement disorders, and facial dysmorphism. The differences in symptom frequencies observed in the unpublished individuals compared to those of published, and recognition of previously underemphasized facial features are likely to be due to the small sizes of the previous cohorts, which underlines the importance of larger cohorts for the phenotype descriptions of rare genetic disorders.
Subject(s)
Key words

Full text: 1 Collection: 01-internacional Database: MEDLINE Main subject: Transcription Factors / Neurodevelopmental Disorders / Intellectual Disability / Movement Disorders Type of study: Diagnostic_studies / Prognostic_studies Limits: Humans Language: En Journal: Clin Genet Year: 2022 Document type: Article Affiliation country:

Full text: 1 Collection: 01-internacional Database: MEDLINE Main subject: Transcription Factors / Neurodevelopmental Disorders / Intellectual Disability / Movement Disorders Type of study: Diagnostic_studies / Prognostic_studies Limits: Humans Language: En Journal: Clin Genet Year: 2022 Document type: Article Affiliation country:
...